FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000410352> ?p ?o ?g. }

• W2000410352 endingPage "529" @default.
• W2000410352 startingPage "520" @default.
• W2000410352 abstract "Peripheral neuropathy represents an important complication of diabetes involving a spectrum of structural, functional and biochemical alterations in peripheral nerves. Recent observations obtained in our laboratory have shown that the levels of neuroactive steroids present in the sciatic nerve of rat raised diabetic by a single injection of streptozotocin (STZ) are reduced and that, in the same experimental model, treatment with neuroactive steroids, such as progesterone, testosterone and their derivatives show neuroprotective effects. On this basis, an interesting therapeutic strategy could be to increase the levels of neuroactive steroids directly in the nervous system. With this perspective, ligands of translocator protein-18 kDa (TSPO) may represent an interesting option. TSPO is mainly present in the mitochondrial outer membrane, where it promotes the translocation of cholesterol to the inner mitochondrial membrane, and, as demonstrated in other cellular systems, it allows the transformation of cholesterol into pregnenolone and the increase of steroid levels. In the diabetic model of STZ rat, we have here assessed whether treatment with Ro5-4864 (i.e., a ligand of TSPO) could increase the low levels of neuroactive steroids in sciatic nerve and consequently to be protective in this experimental model. Data obtained by liquid chromatography-tandem mass spectrometry show that treatment with Ro5-4864 was able to significantly stimulate the low levels of pregnenolone, progesterone and dihydrotestosterone observed in the sciatic nerves of diabetic rats. The treatment with Ro5-4864 also counteracted the impairment of NCV and thermal threshold, restored skin innervation density and P0 mRNA levels, and improved Na+,K+-ATPase activity. In conclusion, data here reported show for the first time that a TSPO ligand, such as Ro5-4864, is effective in reducing the severity of diabetic neuropathy through a local increase of neuroactive steroid levels." @default.
• W2000410352 created "2016-06-24" @default.
• W2000410352 creator A5000837079 @default.
• W2000410352 creator A5008522126 @default.
• W2000410352 creator A5030225047 @default.
• W2000410352 creator A5041994767 @default.
• W2000410352 creator A5049923494 @default.
• W2000410352 creator A5057318573 @default.
• W2000410352 creator A5062077189 @default.
• W2000410352 creator A5063521042 @default.
• W2000410352 creator A5064375891 @default.
• W2000410352 creator A5078228530 @default.
• W2000410352 creator A5089617545 @default.
• W2000410352 date "2009-12-01" @default.
• W2000410352 modified "2023-10-11" @default.
• W2000410352 title "Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy" @default.
• W2000410352 cites W1523342958 @default.
• W2000410352 cites W1702029570 @default.
• W2000410352 cites W1775749144 @default.
• W2000410352 cites W178117275 @default.
• W2000410352 cites W1965008471 @default.
• W2000410352 cites W1965133186 @default.
• W2000410352 cites W1965660436 @default.
• W2000410352 cites W1973388458 @default.
• W2000410352 cites W1975943627 @default.
• W2000410352 cites W1979007089 @default.
• W2000410352 cites W1980093324 @default.
• W2000410352 cites W1982904143 @default.
• W2000410352 cites W1983072558 @default.
• W2000410352 cites W1984251638 @default.
• W2000410352 cites W1984824196 @default.
• W2000410352 cites W1989665114 @default.
• W2000410352 cites W1990912256 @default.
• W2000410352 cites W1992879638 @default.
• W2000410352 cites W1996401496 @default.
• W2000410352 cites W1998695313 @default.
• W2000410352 cites W2002012248 @default.
• W2000410352 cites W2004921676 @default.
• W2000410352 cites W2005884759 @default.
• W2000410352 cites W2006673837 @default.
• W2000410352 cites W2021170058 @default.
• W2000410352 cites W2024391792 @default.
• W2000410352 cites W2025958954 @default.
• W2000410352 cites W2042033404 @default.
• W2000410352 cites W2042778729 @default.
• W2000410352 cites W2051589181 @default.
• W2000410352 cites W2053040554 @default.
• W2000410352 cites W2053801699 @default.
• W2000410352 cites W2054217719 @default.
• W2000410352 cites W2055699536 @default.
• W2000410352 cites W2057846821 @default.
• W2000410352 cites W2058069935 @default.
• W2000410352 cites W2061613894 @default.
• W2000410352 cites W2070046033 @default.
• W2000410352 cites W2077212501 @default.
• W2000410352 cites W2077939735 @default.
• W2000410352 cites W2083880873 @default.
• W2000410352 cites W2088393628 @default.
• W2000410352 cites W2097329828 @default.
• W2000410352 cites W2102627976 @default.
• W2000410352 cites W2115341402 @default.
• W2000410352 cites W2116806371 @default.
• W2000410352 cites W2118777793 @default.
• W2000410352 cites W2121080481 @default.
• W2000410352 cites W2125179582 @default.
• W2000410352 cites W2134397312 @default.
• W2000410352 cites W2155301275 @default.
• W2000410352 cites W2156683062 @default.
• W2000410352 cites W2156865105 @default.
• W2000410352 cites W4237345048 @default.
• W2000410352 cites W4239149547 @default.
• W2000410352 cites W4294216491 @default.
• W2000410352 doi "https://doi.org/10.1016/j.neuroscience.2009.08.005" @default.
• W2000410352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19665520" @default.
• W2000410352 hasPublicationYear "2009" @default.
• W2000410352 type Work @default.
• W2000410352 sameAs 2000410352 @default.
• W2000410352 citedByCount "83" @default.
• W2000410352 countsByYear W20004103522012 @default.
• W2000410352 countsByYear W20004103522013 @default.
• W2000410352 countsByYear W20004103522014 @default.
• W2000410352 countsByYear W20004103522015 @default.
• W2000410352 countsByYear W20004103522016 @default.
• W2000410352 countsByYear W20004103522017 @default.
• W2000410352 countsByYear W20004103522018 @default.
• W2000410352 countsByYear W20004103522019 @default.
• W2000410352 countsByYear W20004103522020 @default.
• W2000410352 countsByYear W20004103522021 @default.
• W2000410352 countsByYear W20004103522022 @default.
• W2000410352 countsByYear W20004103522023 @default.
• W2000410352 crossrefType "journal-article" @default.
• W2000410352 hasAuthorship W2000410352A5000837079 @default.
• W2000410352 hasAuthorship W2000410352A5008522126 @default.
• W2000410352 hasAuthorship W2000410352A5030225047 @default.
• W2000410352 hasAuthorship W2000410352A5041994767 @default.
• W2000410352 hasAuthorship W2000410352A5049923494 @default.
• W2000410352 hasAuthorship W2000410352A5057318573 @default.
• W2000410352 hasAuthorship W2000410352A5062077189 @default.

• next